Diagnostic Performance and Clinical Impact of (68)Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)

Biochemical recurrence (BCR) is a clinical challenge in prostate cancer (PCa) patients, as recurrence localization guides subsequent therapies. The use of PET with prostate-specific membrane antigen (PSMA) provides better accuracy than conventional imaging practice. This prospective, multicenter, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerci, Juliano J., Fanti, Stefano, Lobato, Enrique E., Kunikowska, Jolanta, Alonso, Omar, Medina, Sevastian, Novruzov, Fuad, Lengana, Thabo, Granados, Carlos, Kumar, Rakesh, Rangarajan, Venkatesh, Al-Ibraheem, Akram, Hourani, Mukbil, Ali, Nor S., Ahmad, Azra, Keidar, Zohar, Küçük, Ozlem, Elboga, Umut, Bogoni, Mateos, Paez, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805782/
https://www.ncbi.nlm.nih.gov/pubmed/34215674
http://dx.doi.org/10.2967/jnumed.120.261886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805782/
https://www.ncbi.nlm.nih.gov/pubmed/34215674
http://dx.doi.org/10.2967/jnumed.120.261886

Ejemplares similares